Breast cancer with skeletal metastases at initial diagnosis. Analysis to prognosis, course, and therapy;Das primar ossar metastasierte Mammakarzinom. Untersuchungen zu Prognose, Verlauf und Therapie

Geburtshilfe und Frauenheilkunde

Volumn 57, Issue 11, 1997, Pages 629-636

  Solomayer, E F ^a   Diel, I J ^a   Wallwiener, D ^a   Bastert, G ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BONE METASTASIS; BREAST CANCER; CANCER SURVIVAL; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PROGNOSIS; SKELETON;

EID: 0030718504     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1023150     Document Type: Article

References (42)

1. Byar, D. P.: Analysis of Survival Data: Cox and Weibull Models with Covariates. In Mike, V., K. E. Stanley (Eds.): Statistics in Medical Research. John Wiley & Sons, New York, Toronto (1982) 365-401.
2. Blanco, G., K. Holli, M. Heikkinen, O.-P. Kallioniemi, P. Taskinen: Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading. Br. J. Cancer (1990) 142-146.
3. Carter, C. L., C. Allen, D. E. Henson: Relation of tumor size, lymph node status, and survival in 24740 breast cancer cases. Cancer 63 (1989) 181-187.
4. Coleman, R. E., R. D. Rubens: The clinical course of bone metastases from breast cancer. Br. J. Cancer 55 (1987) 61-66.
5. Coleman, R. E., I. Fogelman, R. D. Rubens: Hypercalcaemia and breast cancer - an increased humoral component in patients with liver metastases. Eur. J. Surg. Oncol. 14 (1988) 423.
6. Costa, S. D., I. J. Diel, E.-F. Solomayer, G. von Minkwitz, G. Bastert: Systemic treatment of bone metastases: review of literature and retrospective analysis of 718 breast cancer patients. In Diel, I. J., M. Kaufmann, G. Bastert (Eds.): Metastatic Bone Disease. Fundamental and Clinical Aspects. Springer, Berlin, Heidelberg (1994) 133-143.
7. Cox, D. R.: Regression Models and Life-Tables. Journal of Royal Statistical Society 34B (1972) 187-220.
8. Croton, R., T. Cooke, S. Holt, W. D. George, R. Nicoloson, K. Griffiths: Oestrogen receptors and survival in early breast cancer. Br. Med. Journal 283 (1981) 1289-1291.
9. Cutler, S. J., M. H. Myers: Clinical classification of extent of disease in cancer of the breast. J. Natl. Cancer Inst. 39 (1967) 193-203.
10. Cutler, S. J., A. J. Asire, S. G. Taylor: Classification of patients with disseminated cancer of the breast. Cancer 24 (1969) 861-869.
11. Devit, J. E.: The enigmatic behavior of breast cancer. Cancer 27 (1971) 12-17.
12. Diel, I. J., M. Kaufmann, S. D. Costa, G. Bastert: Monoclonal Antibodies to Detect Breast Cancer Cells in Bone Marrow. In DeVita, V. T., S. Hellman, S. A. Rosenberg (Eds.): Important Advances in Oncology 1994. Lippincott, Philadelphia (1994) 143-164.
13. Diel, I. J., M. Kaufmann, S. D. Costa, R. Holle, G. von Minckwitz, E.-F. Solomayer, S. Kaul, G. Bastert: Breast cancer patients with micrometastatic tumor cells in bone marrow at primary surgery - Prognostic impact in comparison to nodal status. J. Natl. Cancer. Inst. 88 (1996) 1652-1658.
14. Diel, I. J., E.-F. Solomayer: Bisphosphonate in der antiosteolytischen Therapie des metastasierten Mammakarzinoms. Zentr. Gyn. 118 (1996) 582-587.
15. Fey, M. F., K. W. Brunner, R. W. Sonntag: Prognostic factors in metastatic breast cancer. Cancer Clin. Trials 4 (1981) 237.
16. Galasko, C. S. B.: The anatomy and pathways of skeletal metastases. In Weiss, L., A. H. Gilbert (Eds.): Bone metastasis. Hall. Boston (1981) 49-63.
17. 17 Galasko, C. S. B.: Skeletal metastases. Butterworths, London, Boston (1986).
18. Hayward, J. L., P. P. Carbone, J. C. Heuson, S. Kumaoka, A. Segaloff, R. D. Rubens: Assessment of response to therapy in advanced breast cancer. Eur. J. Cancer 13 (1977) 89-94.
19. Henderson, I. C., G. P. Canellos: Cancer of the breast; The past decade. Parts I and II. N. Engl. J. Med. 302 (1980) 17-30, 78-88.
20. Hietanen, P., M. Miettinen, J. Mäkinen: Survival after first recurrence in breast cancer. Eur. J. Cancer Clin. Oncol. 22 (1986) 913-919.
21. Hortobagyi, N. G.: Bone Metastases in Breast Cancer Patients. Seminars in Oncology 4 (1991) 1-15.
22. International Union Against Cancer: Assessment of response to therapy in advanced breast cancer. Br. J. Cancer 35 (1977) 292-298.
23. Kamby, C., B. B. Rasmussen, B. Kristensen: Prognostic indicators of metastatic bone disease in human breast cancer. Cancer 68 (1991) 2045-2050.
24. Kaplan, E. L., P. Meier: Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc. 53 (1958) 457-481.
25. Lee Y.-T.: Patterns of metastasis and natural course of breast carcinoma. Cancer Met. Rev. 4 (1985) 153-172.
26. Leone, B. A., A. Romero, M. G. Rabinovich, C. T. Vallejo, A. Bianco, J. E. Perez, M. Machiavelli, R. Rodriquez, L. A. Alvarez: Stage IV Breast Cancer: Clinical Course and Survival of Patients with Osseous Versus Extraosseous Metastases at Initial Diagnosis. Am. J. Clin. Oncol. 11 (1988) 618-622.
27. Levine, P. H., S. C. Steinhorn, L. G. Ries, J. L. Aron: Inflammatory breast cancer: the experience of the surveillance, epidemiology, and end results (SEER) program. J. Natl. Cancer Inst. 71 (1985) 291-297.
28. Nemoto, T., J. Vana, R. N. Bedwani, H. W. Baker, F. H. McGregor, G. P. Murphy: Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45 (1980) 2917-2924.
29. Nagel, G. A., W. Holtkamp, H.-E. Wander: Biologische und klinische Prognosefaktoren metastasierender Mammakarzinome. In F. Jubli, G. A. Nagel, M. Kaufmann (Hrsg.): Neue Wege in der Brustkrebsbehandlung. Zuckschwerdt, München, Bern (1983) 91-105.
30. Nielsen, O. S., A. J. Munro, J. F. Tannock: Bone metastases: pathophysiology and management policy. J. Clin. Oncol. 9 (1991) 509-524.
31. Paterson, A. H. G., O. Szafran, A. W. Lees, J. Hanson: Prognostic factors at presentation and their relevance to the natural history of breast cancer. Rev. Endocr. Related Cancer 14, suppl. (1984) 35-39.
32. Perez, J. E., M. Machiavelli, B. A. Leone, A. Romero, M. G. Rabinowich, C. T. Vallejo, A. Bianco, R. Rodriquez, M. A. Cuevas, L. A. Alvarez: Bone-only versus visceral-only metastatic pattern in breast cancer: analysis of 150 patients. Am. J. Clin. Oncol. 13 (1990) 294-298.
33. Peto, R., M. C. Pike, P. Armitage, N. E. Breslow, D. R. Cox, S. V. Howard, N. Mantel, K. McPherson, J. Peto, P. G. Smith: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br. J. Cancer 35 (1977) 1-39.
34. Powles, T. J.: Clodronate: the potential for the future. Bone 12. suppl. 1 (1991) 43-44.
35. Sherry, M. M., F. A. Greco, D. A. Johnson, J. D. Hainsworth: Breast Cancer with Skeletal Metastases at Initial Diagnosis. Cancer 58 (1986A) 178-182.
36. Sherry, M. M., F. A. Greco, D. A. Johnson, J. D. Hainsworth: Metastatic breast cancer confined to the skeletal system: an indolent disease. Am. J. Med. 81 (1986 B) 381-386.
37. Smalley, R. V., J. Carpenter, A. Bartolucci, C. Vogel, S. Krauss: A comparison of cyclophosphamide. adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone (CMFVP) in patients with metastatic breast cancer. Cancer 40 (1977) 625-632.
38. Smalley, R. V., D. M. Scogna, L. S. Malmud: Advanced breast cancer with bone-only metastases. A chemotherapeutically responsive pattern of metastases. Am. J. Clin. Oncol. 5 (1982) 161-166.
39. Stewart, J. F., R. J. King, S. A. Sext, R. R. Millis, R. D. Rubens, J. L. Hayward: Oestrogen receptors, sites of metastatic disease and survival in recurrent breast cancer. Eur. J. Cancer 17 (1981) 449-461.
40. Yamashita, K., T. Ueda, Y. Koyama, H. Inaji, K. Yonenobu, K. Ono: Breast cancer with bone-only metastases. Cancer 68 (1991) 634-637.
41. Valagussa, P., G. Bonadonna, U. Veronesi: Patterns of relapse and survival following radical mastectomy. Cancer 41 (1978) 1170-1178.
42. Wander, H.-E.: Überlebenszeiten beim Mammakarzinom. Karger, Basel, München (1990).